Singaporean medical service provider LYC Healthcare's IPO pricing of US$4/share raised 67% to US$25 million

The Zhitong Finance App learned that LYC Healthcare, which operates medical clinics and orthopedic surgery centers in Singapore, raised the proposed issuance scale of its upcoming initial public offering (IPO) on Tuesday. The company currently plans to issue 6.3 million shares at a proposed offering price of $4 per share to raise $25 million. Previously, the company has submitted documents and plans to issue 3 million shares, with an issue price range of 4 to 6 US dollars per share. According to the adjusted distribution scale, LYC Healthcare expects to raise 67% more capital than previously anticipated, and the corresponding market value will reach US$137 million. The company plans to list on NASDAQ, but the stock code has yet to be determined.

Established in 2017, LYC Healthcare is a multi-disciplinary specialty medical service provider based in Singapore. It provides integrated musculoskeletal medical services through two operating subsidiaries, 5 medical clinics, and in-house advanced imaging facilities. The company has 4 doctors, including 2 specialists, who can perform computer-guided total hip and knee replacement surgery, as well as minimally invasive and minimally invasive interventional procedures; it also provides MRI, CT, X-ray, bone density (BMD) and ultrasound imaging tests, and provides on-site physical therapy services through a three-year partnership. The company treats patients with degenerative joint diseases, spinal diseases, sports injuries, metabolic diseases, and osteoporosis. Its services include health screening, diagnostic scans, treatment, and rehabilitation. According to the data, the company's revenue for the 12 months ended March 31, 2025 was US$14 million.